Hormone Health22 min read

I Love My Partner. So Where Did My Sex Drive Go?

Why desire can fade in midlife even when love hasn't — and what a real evaluation for low libido actually looks like.

Written by Mallory Jones, MSN, APRN, FNP-C, CWHSPublished September 8, 2026Last medically reviewed September 7, 2026
Mature woman sitting by a window, looking thoughtfully into the distance
Key takeaways
  • 01Sexual desire is influenced by hormones, sleep, stress, pain, medications, mental health, body image, and relationship dynamics — not hormones alone.
  • 02There is no medically required amount of sex to want. What matters is whether the change bothers you.
  • 03Responsive desire means interest can appear after sexual activity begins; low spontaneous desire does not automatically mean a disorder.
  • 04Testosterone can help some women with appropriately diagnosed HSDD, but it is not a treatment for general menopause symptoms.
  • 05FDA-approved HSDD medications include Addyi and Vyleesi; Addyi's indication was expanded in December 2025 to include women under 65 regardless of reproductive status.

You still love your partner.

You may still find them attractive.

Your relationship may even be good.

But when it comes to sex?

You just don't think about it anymore.

Maybe you used to initiate sex and now you rarely do.

Maybe your partner touches you and your first thought is:

Please don't let this turn into sex.

Maybe you enjoy sex once it gets going — but you almost never feel the urge to start it.

Maybe you want to want sex, but your body and brain just don't seem interested.

Or maybe you've started wondering whether this means something bigger:

Do I not love my partner the same way anymore?

For a lot of women in perimenopause and menopause, the answer is much more complicated than that.

Your libido is not controlled by one hormone

When sexual desire changes in midlife, women are often told one of two things:

"It's menopause."

or

"Your testosterone must be low."

Neither explanation is good enough by itself.

Sexual desire is influenced by hormones, but also by:

  • Sleep
  • Stress
  • Pain
  • Vaginal dryness
  • Medications
  • Mental health
  • Body image
  • Relationship dynamics
  • Alcohol or other substances
  • Medical conditions
  • Whether sex is actually pleasurable
  • What else is happening in your life

The Menopause Society emphasizes that sexual health in midlife is influenced by hormonal, physical, psychological, relationship, social, and medical factors — not hormones alone. Some women notice a significant decrease in desire at menopause, while others experience little change or even increased interest.

So instead of immediately asking:

"Which hormone am I low in?"

I think a much better question is:

"What is getting in the way of desire?"

First: there is no "correct" amount of sex to want

This matters.

There is no medically required number of times per week you should want sex.

There is no normal libido score everyone should reach.

And wanting sex less frequently than you did at 25 does not automatically mean something is wrong.

The Menopause Society specifically notes that there is no universal standard for how much sexual activity or sexual desire a person should have.

What matters much more is whether you are bothered by the change.

There is a big difference between:

"I rarely think about sex anymore, and I'm completely fine with that."

and:

"I miss wanting sex. This change bothers me, and I want that part of myself back."

The second deserves a conversation.

Maybe your desire isn't gone — it just works differently now

One of the most helpful things women can learn is that sexual desire does not always have to come before sexual activity.

There are different patterns of desire.

Spontaneous desire

This is the version we're usually taught.

You randomly think about sex.

You feel horny.

You initiate.

Sexual desire happens first.

That is real.

But it is not the only normal pattern.

Responsive desire

Sometimes interest appears after affection or sexual stimulation begins.

You may spend the entire day without thinking about sex once.

Then maybe you:

  • Start cuddling
  • Kiss for a while
  • Get a massage
  • Use a vibrator
  • Start touching
  • Have time to relax

And somewhere along the way your brain says:

Actually, this feels pretty good.

That is responsive desire.

ACOG specifically notes that some women normally do not experience sexual desire until sexual activity has already started.

So if you think:

"I enjoy sex when we have it. I just never think to initiate it anymore."

that does not automatically mean you have a libido disorder.

Menopause can affect desire without directly "turning libido off"

Sometimes menopause affects sexual interest indirectly.

Imagine trying to feel interested in sex when you're:

  • Waking up repeatedly at night
  • Having night sweats
  • Exhausted the next day
  • Anxious
  • Irritable
  • Experiencing vaginal dryness
  • Worried penetration will hurt
  • Feeling uncomfortable in your changing body

That's a lot of competition.

The Menopause Society notes that menopause-related sleep disruption, vaginal dryness, pain, changing body image, social stressors, and medical conditions can all affect sexual interest and satisfaction.

Sometimes improving those problems improves libido without prescribing a medication specifically for sexual desire.

If sex hurts, of course you may stop wanting it

This sounds obvious.

But it gets missed all the time.

If penetration burns every time you have sex, your brain starts learning:

Sex = pain.

Eventually, you may stop becoming interested in something your body expects to hurt.

That does not necessarily mean your underlying sexual desire disappeared.

It may mean your body is protecting you.

Pain with sex can come from:

  • Genitourinary syndrome of menopause
  • Vaginal dryness
  • Pelvic-floor muscle tension
  • Vulvodynia
  • Infection
  • Vulvar skin disorders
  • Endometriosis
  • Scar tissue
  • Pelvic conditions
  • Previous surgery or trauma

ACOG recognizes pain, arousal problems, low desire, orgasm difficulties, medication effects, and pelvic-floor problems as overlapping sexual-health concerns.

So when someone tells me:

"My libido is gone."

I also want to know:

"Does sex hurt?"

Because sometimes we need to fix the pain before we decide there is a primary desire problem.

Vaginal estrogen may help sex — but it is not a libido medication

If vaginal dryness or GSM is contributing to painful penetration, treating those symptoms can make sex more comfortable.

And if sex stops hurting?

You may understandably become more interested in having it again.

But this is an important distinction:

Local vaginal estrogen is not a direct treatment for HSDD.

Its benefit to sexual desire is generally indirect — by improving vaginal dryness, tissue comfort, and painful penetration.

Likewise, systemic estrogen can improve menopause symptoms such as hot flashes, night sweats, and sleep disruption, which may indirectly improve sexual function.

But systemic estrogen alone is not considered a primary treatment for hypoactive sexual desire disorder.

Sometimes you're simply exhausted

Midlife is not exactly known for having a lot of empty space.

You may have:

  • Children at home
  • Teenagers
  • Aging parents
  • A demanding job
  • Financial stress
  • Caregiving responsibilities
  • Chronic sleep deprivation
  • Relationship responsibilities
  • Health concerns of your own

The Menopause Society specifically recognizes that midlife social changes — including caring for children and aging parents, changes in relationships, and other life stressors — can influence sexual health.

Sometimes a woman tells me she has "no libido," but when we talk about her life, she hasn't had a moment where she wasn't responsible for someone else in months.

That matters.

The mental load follows you into the bedroom

You can love your partner deeply and still have trouble switching immediately from:

Did I pay the electric bill?

Did the school email me back?

What am I making for dinner tomorrow?

I have to answer that work message.

to:

I'm ready for sex.

Desire often needs space.

That doesn't mean your relationship is failing.

Your relationship still matters

Relationship dynamics can affect desire too.

Things such as:

  • Resentment
  • Conflict
  • Feeling emotionally disconnected
  • Feeling pressured to have sex
  • Mismatched desire
  • Lack of novelty
  • Lack of affection outside of sex
  • Partner sexual difficulties

can all influence whether sex sounds appealing.

But I also don't like when every woman with a sexual-health concern gets told:

"You just need date night."

Sometimes there is a relationship issue.

Sometimes there is a medical issue.

Frequently there is more than one thing happening.

Your medications may be affecting your sex drive

This is a big one.

Some medications can interfere with desire, arousal, orgasm, or genital sensation.

SSRIs are a particularly common example.

Some women taking antidepressants notice:

  • Less interest in sex
  • Difficulty becoming aroused
  • Delayed orgasm
  • Difficulty reaching orgasm
  • Reduced genital sensation

ACOG specifically lists SSRIs as well as other medications and substances that may contribute to sexual problems.

That doesn't mean you should stop a medication that is helping you.

It means your medication list belongs in the conversation.

Sometimes adjusting a medication, switching agents, or using another strategy can help.

Do not stop an antidepressant abruptly without talking with the clinician prescribing it.

Body image can change desire too

Midlife bodies change.

Your weight may redistribute.

Your abdomen may look different.

Your breasts may change.

Your skin may change.

Your vagina and vulva may look and feel different.

You may not feel as comfortable being seen naked as you once did.

Sometimes the problem isn't:

"I'm no longer attracted to my partner."

It is:

"I don't feel attractive myself."

That can make it difficult to initiate sex, receive touch, or stay mentally present during intimacy.

So when does low desire become HSDD?

You may hear the term hypoactive sexual desire disorder, or HSDD.

HSDD is not simply:

"I don't want sex as often as my partner does."

A diagnosis requires more than that.

The current FDA definition used for HSDD medications describes acquired, generalized HSDD as low sexual desire that causes marked distress or interpersonal difficulty and is not better explained by:

  • Another medical or psychiatric condition
  • Relationship problems
  • Medication or drug effects

The current Addyi label uses exactly this framework.

The personal-distress component is important.

You should not receive a diagnosis simply because someone else thinks you should want more sex.

"Should we check my testosterone?"

Sometimes testosterone testing is appropriate.

But this is one of the biggest misconceptions about female sexual health:

There is no testosterone blood level that diagnoses HSDD.

You cannot look at one number and say:

"That's why your libido is low."

A testosterone level can be useful before and during testosterone treatment for monitoring purposes.

But symptoms and a full sexual-health evaluation matter much more than trying to "optimize" a number.

What about testosterone?

Testosterone can help some women with appropriately diagnosed HSDD.

But this is an area where expectations need to stay realistic.

The evidence supports a modest average improvement in sexual desire and other measures of sexual function in appropriately selected women.

It is not usually a dramatic overnight change.

Some women respond very well.

Some notice a smaller improvement.

Some do not experience enough benefit to justify continuing therapy.

ISSWSH guidance supports systemic testosterone for appropriately evaluated women with HSDD and emphasizes physiologic dosing, monitoring, and a biopsychosocial assessment before treatment.

Testosterone is not an evidence-based treatment for every menopause symptom

Testosterone is sometimes advertised as a treatment for:

  • Fatigue
  • Weight gain
  • Brain fog
  • Mood
  • Muscle loss
  • Aging
  • Low motivation
  • "Hormone imbalance"

But its strongest evidence-based role in women is treatment of HSDD, not general menopause optimization.

That distinction matters.

We should treat the symptom and condition we're actually trying to improve.

How testosterone is given matters

When testosterone is used for HSDD, transdermal therapy is generally preferred.

That means testosterone delivered through the skin in a gel, cream, patch, or similar formulation.

Transdermal therapy produces a more physiologic pattern of exposure and makes it easier to use the very small doses appropriate for women.

ISSWSH guidance specifically describes transdermal therapy as the most physiologic approach.

Why not oral testosterone?

Oral testosterone formulations are generally not recommended.

Older oral preparations have been associated with unfavorable lipid effects and other safety concerns.

ISSWSH specifically advises against oral testosterone preparations and intramuscular injections for HSDD.

More testosterone is not better

This is crucial.

The goal of testosterone therapy in women is not to create the highest testosterone level you can tolerate.

Treatment is intended to keep levels within the physiologic female range.

Higher doses increase the likelihood of androgen-related side effects such as:

  • Acne
  • Increased facial or body hair
  • Scalp hair changes

Short-term randomized trials have generally not shown serious safety concerns when physiologic dosing is used, but long-term cardiovascular and breast safety data remain more limited.

That is why testosterone should be treated as a monitored therapy, not indefinite "optimization."

What about testosterone pellets?

Pellets are commonly promoted for:

  • Libido
  • Fatigue
  • Mood
  • Weight
  • Energy
  • "Hormone balance"

But they are not the preferred evidence-based method of testosterone treatment for HSDD.

One major concern is dosing.

Testosterone pellets can produce supraphysiologic levels, and once implanted, the dose cannot easily be reduced if your level is too high or side effects develop.

ISSWSH specifically states that testosterone implants may produce supraphysiologic levels, do not allow easy dose titration, and therefore are not recommended.

So when testosterone is appropriate, the goal is not:

"How high can we get your testosterone?"

It is:

"What is the lowest physiologic dose that meaningfully improves the symptom we're treating?"

What about compounded testosterone?

This is more complicated in the United States because there is currently no FDA-approved testosterone product specifically formulated for women with HSDD.

Clinicians sometimes have to adapt available formulations.

However, expert guidance generally prefers standardized transdermal products that can be carefully dose-adjusted rather than compounded formulations when appropriate options are available.

The important principles are:

  • Use physiologic female dosing
  • Avoid supraphysiologic levels
  • Monitor symptoms
  • Monitor for androgenic side effects
  • Check testosterone levels appropriately
  • Stop treatment if there is no meaningful benefit

How do you know if testosterone is working?

We are not treating a laboratory number.

We are treating a symptom.

The question is whether the woman experiences meaningful improvement in:

  • Desire
  • Sexual interest
  • Sexual satisfaction
  • Sexual distress

If treatment does not produce a meaningful clinical benefit after an adequate therapeutic trial, continuing indefinitely because the testosterone level "looks good" doesn't make sense.

There are also FDA-approved medications for HSDD

Hormones are not the only option.

And there has been an important recent change in this area.

Flibanserin — Addyi

Flibanserin (Addyi) is an oral, nonhormonal medication taken daily at bedtime.

It is used for acquired, generalized HSDD.

And if you've read that Addyi is only for premenopausal women, that information is now outdated.

The FDA indication changed in December 2025

In December 2025, FDA approved an expanded indication for Addyi.

The current prescribing information states that Addyi is indicated for:

Women younger than 65 years of age with acquired, generalized HSDD.

The indication is now independent of reproductive status.

The FDA approval letter specifically states that the supplemental application extended the indication to women under 65 regardless of reproductive status.

The current label includes clinical-trial data for both premenopausal women and postmenopausal women under age 65.

That is important because many older websites and references still describe Addyi as a premenopausal-only medication.

Addyi is not something you take right before sex

Addyi is taken every night at bedtime.

The FDA-approved dose is 100 mg nightly.

If there is no improvement after eight weeks, the current label recommends discontinuing treatment.

It is not intended to enhance sexual performance.

It is specifically for appropriately diagnosed HSDD.

Addyi and alcohol need a real conversation

The alcohol instructions have changed since Addyi was first approved, so older information online may also be outdated.

The current FDA label says:

If you consume one or two standard alcoholic drinks, wait at least two hours before taking Addyi at bedtime.

If you consume three or more drinks that evening, skip your Addyi dose.

After taking Addyi at bedtime, avoid alcohol until the following day.

This matters because combining Addyi and alcohol too close together can increase the risk of low blood pressure and fainting.

Addyi also has important drug interactions, particularly with moderate or strong CYP3A4 inhibitors, and it is contraindicated in certain settings including hepatic impairment.

It can also cause:

  • Dizziness
  • Sleepiness
  • Nausea
  • Fatigue
  • Insomnia
  • Dry mouth

So this isn't a medication to casually add without reviewing your medications, medical history, and alcohol use.

Bremelanotide — Vyleesi

Bremelanotide (Vyleesi) is another FDA-approved treatment for acquired, generalized HSDD.

It works very differently from Addyi.

It is an injectable medication used as needed before anticipated sexual activity rather than taken every day.

Current FDA labeling indicates Vyleesi for premenopausal women with acquired, generalized HSDD.

It is not FDA-approved for postmenopausal women and is not intended simply to enhance sexual performance.

It can temporarily increase blood pressure and is not appropriate for everyone, particularly women with uncontrolled hypertension or known cardiovascular disease.

Nausea is also a common side effect.

What about libido supplements?

Be careful.

There is no shortage of products marketed as:

  • Libido gummies
  • "Hormone balancing" supplements
  • Aphrodisiac chocolates
  • Testosterone boosters
  • Sexual-enhancement honey
  • Herbal arousal products

The word natural does not guarantee that a product is safe — or even that the label tells you everything inside it.

FDA has repeatedly found hidden prescription ingredients in sexual-enhancement products.

For example, in April 2026, FDA warned consumers about WAP Sensual Enhancement after laboratory testing found undeclared:

  • Sildenafil
  • Tadalafil
  • Flibanserin

Those are active ingredients found in prescription medications including Viagra, Cialis, and Addyi.

The company subsequently recalled the product nationally in May 2026.

FDA later tested additional samples and found other undisclosed ingredients as well.

The problem isn't simply that a supplement might "work."

The problem is that you may unknowingly be taking medications that can interact with your prescriptions or affect your blood pressure, heart rate, or nervous system.

If an over-the-counter product promises prescription-level sexual effects without a prescription?

That should make you more cautious, not less.

Sometimes medication isn't the most important treatment

Depending on what is driving low desire, the most effective treatment may involve:

  • Treating GSM or vaginal pain
  • Improving sleep
  • Treating hot flashes or night sweats
  • Reviewing medications
  • Addressing depression or anxiety
  • Pelvic-floor physical therapy
  • Sex therapy
  • Couples counseling
  • Reducing stress
  • Making space for intimacy
  • Exploring what feels good now
  • Changing expectations around spontaneous versus responsive desire

ACOG also recommends practical strategies such as lubrication, masturbation, exploring different kinds of touch and sexual activity, communicating with a partner, reducing stress, and getting adequate sleep.

That doesn't make low libido "all in your head."

It means female sexual function is complex.

You may need to relearn what turns you on

What worked at 25 may not work exactly the same way at 45.

Maybe you need:

  • More time
  • More direct clitoral stimulation
  • More lubricant
  • A vibrator
  • Different positions
  • More foreplay
  • More privacy
  • More novelty
  • More emotional connection
  • Less pressure
  • Better sleep

There is nothing wrong with learning your body again.

Midlife sexuality does not need to be an attempt to recreate exactly how sex worked 20 years ago.

And yes, masturbation counts

Sometimes masturbation can help answer an important question.

Is the problem:

"I have almost no sexual interest or pleasure in any situation."

or:

"I can still experience pleasure and desire by myself, but something about partnered sex isn't working for me right now."

Those are different clinical conversations.

ACOG specifically includes masturbation and exploring different types of sexual stimulation among strategies women can use when experiencing sexual difficulties.

What should a good low-libido evaluation include?

If you tell a healthcare provider:

"My sex drive has disappeared."

the entire evaluation should not consist of ordering a testosterone level.

A thoughtful evaluation may include:

  • When the change started
  • Whether it was gradual or sudden
  • Whether you ever think about sex
  • Whether desire appears after sexual activity starts
  • Whether the problem happens in every situation
  • Whether sex hurts
  • Vaginal dryness or GSM symptoms
  • Ability to become aroused
  • Ability to orgasm
  • Changes in genital sensation
  • Sleep
  • Hot flashes and night sweats
  • Mood
  • Anxiety
  • Stress
  • Relationship dynamics
  • Medication use
  • Alcohol or other substances
  • Medical conditions
  • Body image
  • Previous sexual experiences
  • Whether the change actually bothers you

That broader biopsychosocial assessment is fundamental to evidence-based HSDD care.

Maybe the question isn't "How do I make myself want sex?"

Sometimes the better question is:

What does a satisfying sex life look like for me now?

Maybe that means intercourse.

Maybe it doesn't.

Maybe you want sex twice a week.

Maybe twice a month.

Maybe you want more affection and less penetrative sex.

Maybe you want to rediscover masturbation.

Maybe you want your orgasms back.

Maybe you want to feel comfortable in your body again.

Maybe you simply miss thinking about sex.

There isn't one correct answer.

But if you miss your sex drive, say something

Women often hesitate to bring this up because they expect to hear:

"That's just aging."

Or:

"You're married. That's normal."

Or:

"Your testosterone is low — here's a pellet."

None of those are an adequate evaluation.

You can love your partner and have low desire.

You can be attracted to someone and rarely think about sex.

You can enjoy sex after it begins and still almost never initiate it.

You can have a "normal" testosterone level and still have a real sexual-health concern.

And you can decide that your current amount of sexual desire is perfectly fine and you don't want treatment at all.

You get to decide whether this is a problem for you.

And if it is, there are things we can evaluate.

There are things we can treat.

And you deserve a healthcare provider who can talk about sexual health without making you feel embarrassed for asking.


This article is for educational purposes and is not intended to diagnose or treat an individual medical condition. Changes in sexual desire can have hormonal, medical, medication-related, psychological, relationship, pelvic-floor, and other causes. Treatment should be individualized based on symptoms, medical history, medications, examination when appropriate, and personal preferences.

References

  • American College of Obstetricians and Gynecologists (ACOG). Your Sexual Health. Current patient guidance. https://www.acog.org/womens-health/faqs/your-sexual-health
  • The Menopause Society. Sexual Health. Current patient education guidance. https://menopause.org/patient-education/menopause-topics/sexual-health
  • Parish SJ, Simon JA, Davis SR, et al. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Sexual Medicine. 2021;18(5):849-867.
  • U.S. Food and Drug Administration. ADDYI (flibanserin) Prescribing Information. Revised December 2025.
  • U.S. Food and Drug Administration. Supplement Approval Letter: ADDYI (flibanserin), NDA 022526/S-013. December 2025.
  • U.S. Food and Drug Administration. VYLEESI (bremelanotide) Prescribing Information.
  • U.S. Food and Drug Administration. WAP Sensual Enhancement May Be Harmful Due to Hidden Drug Ingredients. Updated August 25, 2026.

Related care

If this is what you're working through, read more about Menopause & Perimenopause Hormone Therapy.

Ready for the conversation?

Have a real visit with Mallory.

Telehealth visits with one clinician, continuity between visits, and no rotating staff.